eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2022
vol. 47
 
Share:
Share:
abstract:
Clinical immunology

ELF3-induced miR-182 inhibits adipogenic differentiation in Graves’ orbitopathy by targeting thyrotropin receptor

Sha Wang
1, 2, 3
,
Lu Chen
1, 2, 3
,
Bei Xu
1, 2, 3

  1. Eye Center of Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, P.R. China
  2. Hunan Key Laboratory of Ophthalmology, Changsha 410008, Hunan Province, P.R. China
  3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, P.R. China
Cent Eur J Immunol 2022; 47 (4): 308-322
Online publish date: 2023/01/31
View full text Get citation
 
PlumX metrics:
Introduction:
Graves’ orbitopathy (GO) is a common autoimmune disease, but its specific pathogenesis has not been fully elucidated. MicroRNAs (miRNAs) possess an important regulatory function in the occurrence and development of autoimmune diseases. In the present study, we explored the potential role of miR-182 in the diagnosis of GO.

Material and methods:
The expression of miR-182, thyrotropin receptor (TSHR) and adipocytokines was ascertained by qRT-PCR assay. The triglyceride (TG) content was ascertained by ELISA assay. The lipid droplet content was identified by Oil Red O staining. The relationship between E74-like factor 3 (ELF3), miR-182 and TSHR was confirmed by ChIP, dual-luciferase reporter assay and RIP.

Results:
The expression of miR-182 decreased, while TSHR increased, and adipocytokine (adiponectin, leptin, PPAR-, and AP2) levels were upregulated in preorbital adipose tissue of patients with GO and differential medium induced (DM-induced) 3T3-L1 cells. MiR-182 mimics inhibited adipocytokine expression, TG content and lipid droplets; however, miR-182 inhibitor had the opposite results. TSHR was a target gene of miR-182, and TSHR overexpression (oe-TSHR) reversed the effect of miR-182 mimics on adipogenic differentiation of 3T3-L1 by DM treatment. ELF3 transcription promoted miR-182 expression. Oe-ELF3 inhibited adipocytokine expression and reduced TG content and lipid droplets in DM-induced 3T3-L1 cells. MiR-182 inhibitor reversed the effect of oe-ELF3 on adipogenic differentiation in 3T3-L1.

Conclusions:
ELF3/miR-182/TSHR axis alleviated Graves’ orbitopathy by inhibiting adipogenic differentiation.

keywords:

Graves’ orbitopathy, ELF3, miR-182, TSHR

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.